Literature DB >> 3674957

Synthesis of cysteinylphenol, cysteaminylphenol, and related compounds, and in vivo evaluation of antimelanoma effect.

S Miura1, T Ueda, K Jimbow, S Ito, K Fujita.   

Abstract

Phenolic and catecholic compounds were synthesized, by combination with cysteine or cysteamine through thioether bond, and their antimelanoma and melanocytotoxic effects were evaluated. Among nine compounds tested, 4-S-cysteaminylphenol (CAP) resulted in an increase in the life span (% ILS) of melanoma-bearing mice and in the growth inhibition (% GI) of melanoma tissue. 4-S-Cysteinylphenol (CP) and its methyl ester form also showed some increase in % GI. The 2-S-isomers of CP and CAP and diphenolic derivatives of CP did not show any significant antimelanoma effect. In addition, the s.c. injection of 4-S-CAP and 4-S-CP, in particular 4-S-CAP, caused the depigmentation of black hair which was manifested by loss of functioning melanocytes, as seen under light microscopy. The 4-S-CAP appears to provide a basis for development of a new class of antimelanoma and melanocytotoxic agents that are more stable than catecholic compounds, which have been most widely utilized as a source of rational chemotherapy for malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3674957     DOI: 10.1007/bf00417318

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  23 in total

Review 1.  DTIC (NSC-45388) in malignant melanoma: a perspective.

Authors:  R L Comis
Journal:  Cancer Treat Rep       Date:  1976-02

2.  Survival of mice receiving melanoma transplants is promoted by hydroquinone.

Authors:  W Chavin; E J Jelonek; A H Reed; L R Binder
Journal:  Science       Date:  1980-04-25       Impact factor: 47.728

3.  The cytotoxicity of gamma-L-glutaminyl-4-hydroxybenzene for cells that contain tyrosinase, a study of melanocytes in the hair follicle of the mouse.

Authors:  P C Burger; L A Kemper; F S Vogel
Journal:  Cancer Res       Date:  1979-05       Impact factor: 12.701

4.  Tyrosinase-mediated inhibition of in vitro leucine incorporation into mouse melanoma by 4-isopropylcatechol.

Authors:  H Sugano; I Sugano; K Jimbow; T B Fitzpatrick
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

5.  Structural analogues of L-glutamic Acid gamma-(4-hydroxyanilide) and gamma-(3,4-dihydroxyanilde) as potential agents against melanoma.

Authors:  A Rsoswsky; M M Wick; S H Kim
Journal:  J Med Chem       Date:  1979-09       Impact factor: 7.446

6.  3,4-Dihydroxybenzylamine: a dopamine analog with enhanced antitumor activity against B16 melanoma.

Authors:  M M Wick
Journal:  J Natl Cancer Inst       Date:  1979-12       Impact factor: 13.506

7.  In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.

Authors:  M E Morrison; M J Yagi; G Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Modification of dopa toxicity in human tumour cells.

Authors:  P G Parsons
Journal:  Biochem Pharmacol       Date:  1985-05-15       Impact factor: 5.858

9.  Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.

Authors:  S Ito; S Inoue; Y Yamamoto; K Fujita
Journal:  J Med Chem       Date:  1981-06       Impact factor: 7.446

10.  Characterization of melanogenesis and morphogenesis of melanosomes by physicochemical properties of melanin and melanosomes in malignant melanoma.

Authors:  K Jimbow; Y Miyake; K Homma; K Yasuda; Y Izumi; A Tsutsumi; S Ito
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

View more
  5 in total

Review 1.  Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review.

Authors:  Yasuaki Tamura; Akira Ito; Kazumasa Wakamatsu; Takafumi Kamiya; Toshihiko Torigoe; Hiroyuki Honda; Toshiharu Yamashita; Hisashi Uhara; Shosuke Ito; Kowichi Jimbow
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

2.  In vivo antimelanoma effects of 4-S-cysteaminylphenol, a newly synthesized therapeutic agent specific to melanoma.

Authors:  M Kitagawa; T Nemoto; S Seki; S Ito; T Kasuga
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  Tyrosine transport in a human melanoma cell line as a basis for selective transport of cytotoxic analogues.

Authors:  J M Pankovich; K Jimbow
Journal:  Biochem J       Date:  1991-12-15       Impact factor: 3.857

4.  Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenol.

Authors:  J A Prezioso; N Wang; W D Bloomer
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

5.  The killing effect of 4-S-cysteaminylphenol, a newly synthesised melanin precursor, on B16 melanoma cell lines.

Authors:  I Yamada; S Seki; S Ito; S Suzuki; O Matsubara; T Kasuga
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.